A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more ...

Global health experts have updated the definition and guidelines for heart failure to address its rising prevalence. The ...

An experimental drug for healing heart tissue recently green-lighted for pilot trials in humans may have promise for healing ...

The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC Cardio-Oncology 2026, the annual conference of the European Society of ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...

Cardiology societies unveiled the new universal definition of heart failure, with a new focus on early prevention of HF and ...

Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical ...

Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing ...

Heart failure remains a substantial cause of morbidity and mortality. Despite numerous therapeutic advancements over the past decade, there are populations in whom therapy is insufficient, ...

Explore the plug-in hybrid S-Class with a claimed 115 km electric range, 60 kW DC fast charging and flagship luxury.

The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ...

Patients receiving cancer treatment often face the added complication of side effects affecting the heart, which can lead to the need to discontinue anticancer therapy, reducing its effectiveness.